- Home
- »
- Medical Devices
- »
-
Disinfection Cap Market Size & Share Report, 2026-2033GVR Report cover
Disinfection Cap Market (2026 - 2033)
Size, Share & Trends Analysis Report By Distributors (Retail, Non-retail), By End Use (Hospitals, Clinics), By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa), And Segment Forecasts
Market Size, 2025
$600.0MMarket Estimate, 2026
$700.0MMarket Forecast, 2033
$1,100.0MCAGR, 2026–2033
7.4%Disinfection Cap Market Summary
The global disinfection cap market size was valued at USD 600.0 million in 2025 and is projected to grow from USD 700.0 million in 2026 to USD 1,100.0 million by 2033, at a CAGR of 7.4% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 33.0% in 2025. The market growth is driven by several factors, including the rising prevalence of Hospital Acquired Infections (HAIs) across the globe, the rising adoption of needle-free connectors & catheters for various medical procedures, and stringent regulations for safe injection practices.
Key Market Trends & Insights
- By distributors: The non-retail segment held the largest market share of around 68.0% in 2025.
- By end use: The hospitals segment held the largest market share of over 38.5% in 2025.
Regional Highlights
- Largest regional market: North America (33.0% revenue share, 2025)
- Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
Market Size & Forecast
- Market size in 2025: USD 600.0 Million
- Estimated market size in 2026: USD 700.0 Million
- Projected market size by 2033: USD 1,100.0 Million
- CAGR (2026-2033): 7.4%
Disinfection caps are small devices that cover the end of a catheter and release a disinfectant solution to kill bacteria. They are widely used in hospitals, clinics, and home care settings. Increasing cases of HAIs due to the lack of sanitation and precaution are among the major factors contributing to market growth.

The rise in the number of cases of HAIs is expected to boost the demand for disinfection caps over the forecast period. The increasing prevalence of chronic conditions, such as cancer, positively impacts the use of parenteral nutrition across the country. Parenteral nutrition helps in the administration of vital nutrients, which help in maintaining strength, energy, and hydration levels in patients suffering from a disease. According to statistics published by the WHO, cancer is one of the leading causes of death every year. Moreover, the proportion of cancer cases is estimated to increase over the next couple of decades.
Market Dynamics
The increasing prevalence of cancer is a high-impact driver of the disinfection cap industry, as the caps are used the decontaminate IV connectors used to supply nutrition. Cancer generally leads to a rise in the incidence of stomach ulcers, disturbance in the normal functioning of the GI tract, and development of physical obstructions, thereby resulting in an increased requirement for parenteral nutrition. Moreover, cancer therapies further weaken the human body and deprive it of nutrients to an extent that it may prove to be fatal. In addition, a common symptom associated with cancer is anorexia or unintentional weight loss requiring replenishment through the parenteral route of administration. Thus, such factors are anticipated to boost the market growth over the forecast period.
Even with the rising popularity of disinfection caps in infection prevention, their demand is hindered by the cost and variable clinical acceptance in healthcare organizations. Disinfection caps are single-use disposables, and continuous purchasing results in high operating costs for hospitals and other health care organizations. Due to financial limitations and underfunding in some health care environments, especially in developing nations, most organizations revert to the old method of disinfection, which involves manually scrubbing the hub. ICU Medical’s official product documentation for SwabCab Disinfecting Caps notes that although disinfecting caps are recommended to reduce contamination risks, nursing guidelines still rely on manual disinfection practices, such as scrubbing needleless connectors before every access, and that compliance with these practices can vary significantly across healthcare settings.
One of the key areas of potential growth in the disinfection cap industry is the rising worldwide interest in decreasing hospital-acquired infections (HAIs) and setting higher standards in terms of patient safety. Infection control measures in healthcare systems around the globe are becoming stricter, with special emphasis on IV therapy, where central line-associated bloodstream infections (CRBSIs) represent a common problem. With efforts to lower infection rates and related treatment costs, hospitals are increasingly looking towards innovative passive disinfection methods, including disinfecting caps, which ensure ongoing disinfection of access points between treatments.
Analyst’s Perspective
The disinfection caps market is witnessing strong growth, driven by increasing efforts to reduce catheter-related bloodstream infections (CRBSIs) and healthcare-associated infections (HAIs). Rising use of vascular access devices, outpatient care, and home healthcare is further supporting demand. Growing clinical evidence for passive disinfection technologies is encouraging adoption. Companies focusing on product efficacy, antimicrobial protection, compatibility, and cost-effectiveness are expected to gain a competitive advantage.
Distributor Insights
The non-retail distributor segment led the market with the largest revenue share of around 68.0% in 2025. The non-retail distributor segment includes hospitals, clinics, and other healthcare facilities that use disinfection caps for preventing infections from catheters and IV connectors. The segment's leadership is primarily attributable to the high volume of catheter-related procedures performed in institutional healthcare settings and the stringent infection-prevention protocols implemented across hospitals.
The retail distributor segment comprises pharmacies, online stores, and other outlets that sell disinfection caps to consumers for home care and outpatient usage. The retail distributor segment is also expected to grow at a significant CAGR during the forecast period, due to the rising awareness of and preference for disinfection caps among home care patients and caregivers.
End-use Insights
The hospitals segment led the market with the largest revenue share of over 38.5% in 2025. Hospitals are the major end users of disinfection caps, with high patient footfall. Disinfection caps are used in hospitals to clean and protect the intravenous connectors and catheters that are used for various purposes, such as parenteral nutrition, blood transfusion, chemotherapy, and dialysis. These procedures require sterile and safe equipment to prevent the risk of HAIs that can occur due to contaminated catheters and connectors.
The clinics segment is anticipated to grow at a significant CAGR during the forecast period due to the accessibility and convenience these settings offer. HAIs can cause serious complications and increase the mortality and morbidity of patients. Disinfection caps help in reducing the incidence and severity of HAIs by creating a physical and chemical barrier between the connector and potential contaminants. They also help in saving time and costs associated with manual disinfection methods. Outpatient settings, including clinics, are preferred by patients who do not require hospitalization or intensive care and can be treated at lower costs and with greater convenience.
Regional Insights
North America dominated the global disinfection cap market with the largest revenue share of over 33.0% in 2025. This growth is attributed to the increasing number of surgeries being performed and the presence of advanced healthcare infrastructure in the region.

Asia Pacific Disinfection Cap Market Trends
The disinfection cap market in the Asia Pacific is expected to grow at the fastest CAGR over the forecast period. Disinfection caps are essential for surgical procedures as they reduce the risk of contamination and transmission of infections from one patient to another. In addition, the increasing cases of HAIs are further expected to boost the market growth. The increasing incidence of HAIs, food poisoning, cholera, and typhoid fever is one of the major factors driving the growth of the regional market.
Key Disinfection Cap Company Insights
Companies operating in the market have a strong presence and are continuously investing in research and development. They also employ various strategies, such as mergers & acquisitions, partnerships, collaborations, and product launches, to expand their customer base and geographic reach
Key Disinfection Cap Companies
The following key companies have been profiled for this study on the disinfection cap market
-
3M Company
-
Becton Dickinson and Company
-
ICU Medical Inc.
-
B. Braun Melsungen AG
-
Baxter International Inc.
Recent Developments
- In August 2024, Medline Industries completed the acquisition of Ecolab’s globalsurgical solutions business, including the Microtek product portfolio. While thetransaction extends beyond disinfection caps, it strengthens Medline’s infection prevention and sterile protection offerings, which are closely alignedwith the broader vascular access and infection-control market.
Disinfection Cap Market Report Scope
Report Attribute
Details
Market size in 2025
USD 600.0 million
Estimated market size in 2026
USD 700.0 million
Projected market size by 2033
USD 1,100.0 million
Growth rate
CAGR of 7.4% from 2026 to 2033
Base year for estimation
2025
Historical data
2021 - 2024
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million/billion, and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Distributor, end use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope
U.S.; Canada; UK; Germany; France; Italy; Spain; Sweden; Norway; Denmark; China; Japan; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait
Key companies profiled
3M Company; Becton Dickinson and Company; ICU Medical Inc.; B. Braun Melsungen AG; Baxter International Inc.
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail of customized purchase options to meet your exact research needs. Explore purchase options
Global Disinfection Cap Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global disinfection cap market report based on distributor, end-use, and region:

-
Distributor Outlook (Revenue, USD Million, 2021 - 2033)
-
Retail
-
Non-retail
-
-
End-use Outlook (Revenue, USD Million, 2021 - 2033)
-
Hospitals
-
Clinics
-
Others
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
U.K.
-
Germany
-
France
-
Italy
-
Spain
-
Sweden
-
Norway
-
Denmark
-
-
Asia Pacific
-
China
-
Japan
-
India
-
Australia
-
Thailand
-
South Korea
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
-
Middle East and Africa
-
Saudi Arabia
-
South Africa
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
The global disinfection cap market size was valued at USD 600.0 million in 2025 and is projected to grow from USD 700.0 million in 2026
Some key players operating in the disinfection cap market include BD, 3M, ICU Medical, Merit Medical, and B. Braun Melsungen AG.
The non-retail segment held the largest market share of around 68.0% in 2025.
The global disinfection cap market is expected to grow at a CAGR of 7.4% from 2026 to 2033, reaching USD 1,100.0 million by 2033.
North America dominated with a revenue share of 33.0% in 2025.
About the Author(s)
Medical Devices Research Team
Healthcare · Medical DevicesThis report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs — add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.